CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

NCT06847269 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Refractory Acute Lymphoblastic Leukemia

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Mesna
BIOLOGICAL: CD19-CAR T cell Infusion

Sponsor

St. Jude Children's Research Hospital